Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Profit After Tax: 2017-2024

Historic Profit After Tax for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to -$283.0 million.

  • Arcus Biosciences' Profit After Tax fell 46.74% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$433.0 million, marking a year-over-year decrease of 60.37%. This contributed to the annual value of -$283.0 million for FY2024, which is 7.82% up from last year.
  • As of FY2024, Arcus Biosciences' Profit After Tax stood at -$283.0 million, which was up 7.82% from -$307.0 million recorded in FY2023.
  • Over the past 5 years, Arcus Biosciences' Profit After Tax peaked at $53.0 million during FY2021, and registered a low of -$307.0 million during FY2023.
  • For the 3-year period, Arcus Biosciences' Profit After Tax averaged around -$285.7 million, with its median value being -$283.0 million (2024).
  • In the last 5 years, Arcus Biosciences' Profit After Tax spiked by 143.09% in 2021 and then crashed by 603.77% in 2022.
  • Yearly analysis of 5 years shows Arcus Biosciences' Profit After Tax stood at -$123.0 million in 2020, then soared by 143.09% to $53.0 million in 2021, then tumbled by 603.77% to -$267.0 million in 2022, then decreased by 14.98% to -$307.0 million in 2023, then rose by 7.82% to -$283.0 million in 2024.